PROK
ProKidney Corp.
NASDAQ: PROK · HEALTHCARE · BIOTECHNOLOGY
$1.82
-0.55% today
Updated 2026-04-29
Market cap
$552.59M
P/E ratio
—
P/S ratio
618.80x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $6
Volume
0.8M
ProKidney Corp. (PROK) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $19.61M | $16.70M | $40.30M | $518.00M | $420.55M | $441.07M |
| Cash & equivalents | $15.23M | $4.58M | $20.56M | $490.25M | $60.65M | $99.12M |
| Current assets | $15.42M | $5.58M | $27.27M | $504.72M | $374.15M | $395.88M |
| Total liabilities | $3.72M | $6.84M | $13.38M | $13.06M | $29.22M | $39.44M |
| Current liabilities | $2.71M | $5.50M | $12.31M | $10.87M | $25.04M | $36.22M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $15.88M | $9.86M | $26.92M | $-1.10B | $-1.10B | $-994.95M |
| Retained earnings | $-79.61M | $-106.36M | $-161.51M | $-1.10B | $-1.14B | $-1.20B |
| Accounts receivable | — | — | — | — | $1.38M | $2.45M |
| Inventory | — | — | — | — | — | — |
| Goodwill | — | $641358.00 | $427572.00 | — | — | — |